Clinical Research Directory
Browse clinical research sites, groups, and studies.
CPL-01 in the Management of Postoperative Pain After Bunionectomy
Sponsor: Cali Pharmaceuticals LLC
Summary
Subjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.
Official title: A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
616
Start Date
2023-05-22
Completion Date
2025-10-06
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
Local anesthetic injection of CPL-01
Local anesthetic injection (CPL-01)
Naropin, 0.5% Injectable Solution
Local anesthetic injection (positive control \[Naropin\])
Placebo
Local anesthetic injection (negative control \[saline placebo\])
Morphine rescue medication
Rescue opioid (IV morphine) allowed if requested
Acetaminophen rescue medication
Rescue non-opioid (oral acetaminophen) allowed if requested
Oxycodone rescue medication
Rescue opioid (PO oxycodone) allowed if requested
Bunionectomy
Operative bunion repair
Locations (1)
Todd Bertoch
Salt Lake City, Utah, United States